Analysts Recommendations ICU Medical, Inc.(NASDAQ:ICUI): NantKwest, Inc.(NASDAQ:NK)

0
2

ICU Medical, Inc. (ICUI) will report its next earnings on Feb 27 AMC. The company reported the earnings of $1.94/Share in the last quarter where the estimated EPS by analysts was $1.63/share. The difference between the expected and actual EPS was $0.31/share, which represents an Earnings surprise of 19%.

Many analysts are providing their Estimated Earnings analysis for ICU Medical, Inc. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $1.63/share. These analysts have also projected a Low Estimate of $1.56/share and a High Estimate of $1.69/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for ICU Medical, Inc. as 296.3 Million. According to these analysts, the Low Revenue Estimate for ICU Medical, Inc. is 294.6 Million and the High Revenue Estimate is 297.4 Million. The company had Year Ago Sales of 318.97 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for ICUI to be -38%. They are projecting Next Quarter growth of -16.08%. For the next 5 years, ICU Medical, Inc. is expecting Growth of 12.72% per annum, whereas in the past 5 years the growth was -15.69% per annum.

Some buy side analysts are also providing their Analysis on ICU Medical, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.71 and Average Volume (3 months) is 149.52 million. The company’s P/E (price to earnings) ratio is 40.38 and Forward P/E ratio of 24.59.

The company shows its Return on Assets (ROA) value of 6.2%. The Return on Equity (ROE) value stands at 7.6%. While it’s Return on Investment (ROI) value is 6.8%.

While looking at the Stock’s Performance, ICU Medical, Inc. currently shows a Weekly Performance of 3.25%, where Monthly Performance is -7.06%, Quarterly performance is 1.43%, 6 Months performance is 18.69% and yearly performance percentage is -19.69%. Year to Date performance value (YTD perf) value is 1.31%. The Stock currently has a Weekly Volatility of 10.01% and Monthly Volatility of 8.96%.

NantKwest, Inc. (NK) will report its next earnings on Mar 25. The company reported the earnings of $-0.16/Share in the last quarter where the estimated EPS by analysts was $-0.18/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 11.1%.

Many analysts are providing their Estimated Earnings analysis for NantKwest, Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.2/share. These analysts have also projected a Low Estimate of $-0.2/share and a High Estimate of $-0.2/share.

Some buy side analysts are also providing their Analysis on NantKwest, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 1.99 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -37.2%. The Return on Equity (ROE) value stands at -44.9%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, NantKwest, Inc. currently shows a Weekly Performance of 9.52%, where Monthly Performance is -38.85%, Quarterly performance is -12.06%, 6 Months performance is 157.76% and yearly performance percentage is 82.32%. Year to Date performance value (YTD perf) value is -21.11%. The Stock currently has a Weekly Volatility of 12.83% and Monthly Volatility of 14.00%.

SHARE